News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gengos Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Bought 422 shares
@ $3.3576, valued at
$1.4k
Bought 2,859 shares
@ $3.4, valued at
$9.7k
Bought 11,719 shares
@ $3.4395, valued at
$40.3k
|
|
| 06/06/2023 |
4
| Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Bought 10,012 shares
@ $2.75, valued at
$27.5k
Bought 6,582 shares
@ $2.8598, valued at
$18.8k
Bought 3,418 shares
@ $2.945, valued at
$10.1k
Bought 15,000 shares
@ $3, valued at
$45k
Bought 10,000 shares
@ $2.9997, valued at
$30k
Bought 10,000 shares
@ $2.9999, valued at
$30k
Bought 10,000 shares
@ $3.0154, valued at
$30.2k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/15/2018 |
4
| Gengos Andrew (COO) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 10,000 options to buy
@ $9.95, valued at
$99.5k
|
|
| 12/22/2017 |
4
| Gengos Andrew (See Remarks) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 154,000 options to buy
@ $14.71, valued at
$2.3M
|
|
| 10/10/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2016 |
4
| Gengos Andrew (President and CEO) has filed a Form 4 on ImmunoCellular Therapeutics, Ltd.|
Txns:
| Granted 150,000 shares
@ $0
Granted 350,000 options to buy
@ $0.33, valued at
$115.5k
|
|
|
|